$RENB
RENOVARO INC. Stock $renb

$renb Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000173112224001811 Filed on November 14, 2024

Income Statement

Concept	2024 Q3	2023 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.301M	$8.290M
YoY Change	-36.05%	81.92%
% of Gross Profit
Research & Development	$390.2K	$566.6K
YoY Change	-31.14%	-78.25%
% of Gross Profit
Depreciation & Amortization	$32.39K	$27.26K
YoY Change	18.8%	-4.02%
% of Gross Profit
Operating Expenses	$53.34M	$8.884M
YoY Change	500.38%	23.55%
Operating Profit	-$53.34M	-$8.884M
YoY Change	500.38%	23.55%
Interest Expense	-$123.5K	-$170.0K
YoY Change	-27.36%	-277.85%
% of Operating Profit
Other Income/Expense, Net	$9.127M	-$290.9K
YoY Change	-3237.19%	-42.86%
Pretax Income	-$44.21M	-$9.175M
YoY Change	381.87%	19.16%
Income Tax
% Of Pretax Income
Net Earnings	-$44.21M	-$9.175M
YoY Change	381.87%	19.16%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.28	-$0.14
Diluted Earnings Per Share	-$0.28	-$0.14
COMMON SHARES
Basic Shares Outstanding	156.6M shares	65.70M shares
Diluted Shares Outstanding	156.6M shares	64.48M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$220.6K	$500.0K
YoY Change	-55.89%	-93.73%
Cash & Equivalents	$220.6K	$523.5K
Short-Term Investments
Other Short-Term Assets	$485.2K	$300.0K
YoY Change	61.74%	86.76%
Inventory
Prepaid Expenses
Receivables		$1.100M
Other Receivables		$0.00
Total Short-Term Assets	$1.948M	$1.906M
YoY Change	2.2%	-76.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$452.2K	$482.5K
YoY Change	-6.28%	-13.78%
Goodwill	$118.2M	$11.64M
YoY Change	915.22%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$119.4M	$55.17M
YoY Change	116.46%	-25.82%
Total Long-Term Assets	$119.9M	$55.66M
YoY Change	115.4%	-25.73%
TOTAL ASSETS
Total Short-Term Assets	$1.948M	$1.906M
Total Long-Term Assets	$119.9M	$55.66M
Total Assets	$121.8M	$57.56M
YoY Change	111.65%	-30.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.40M	$5.400M
YoY Change	111.15%	15.32%
Accrued Expenses	$5.359M	$797.8K
YoY Change	571.8%	-23.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.607M	$3.700M
YoY Change	-29.55%	208.33%
Total Short-Term Liabilities	$23.04M	$10.10M
YoY Change	128.17%	41.02%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$710.3K	$700.0K
YoY Change	1.47%	-25.12%
Total Long-Term Liabilities	$710.3K	$720.8K
YoY Change	-1.46%	-87.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.04M	$10.10M
Total Long-Term Liabilities	$710.3K	$720.8K
Total Liabilities	$23.75M	$10.82M
YoY Change	119.53%	-15.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$368.9M	-$253.2M
YoY Change	45.69%	19.41%
Common Stock	$15.76K	$6.571K
YoY Change	139.89%	18.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$98.09M	$46.75M
YoY Change
Total Liabilities & Shareholders Equity	$121.8M	$57.56M
YoY Change	111.65%	-30.71%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$44.21M	-$9.175M
YoY Change	381.87%	19.16%
Depreciation, Depletion And Amortization	$32.39K	$27.26K
YoY Change	18.8%	-4.02%
Cash From Operating Activities	-$2.016M	-$2.777M
YoY Change	-27.4%	-1.53%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$1.060M
YoY Change	-100.0%
Cash From Investing Activities	$0.00	-$1.058M
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.029M	$2.563M
YoY Change	-20.82%	57.71%
NET CHANGE
Cash From Operating Activities	-$2.016M	-$2.777M
Cash From Investing Activities	$0.00	-$1.058M
Cash From Financing Activities	$2.029M	$2.563M
Net Change In Cash	$104.00	-$1.351M
YoY Change	-100.01%	12.56%
FREE CASH FLOW
Cash From Operating Activities	-$2.016M	-$2.777M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001527728
CY2024Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	81697	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1150474	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	119432266	usd
CY2024Q3	us-gaap	Assets Assets	121832637	usd
CY2024Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	11402223	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5359454	usd
CY2024Q3	RENB	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	3060000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	23035379	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	710260	usd
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration		usd
CY2024Q3	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2023Q3	RENB	Cancellation Of Restricted Stock Awards CancellationOfRestrictedStockAwards		usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Period Increase Decrease FiniteLivedIntangibleAssetsPeriodIncreaseDecrease		usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2024Q3	us-gaap	Indefinite Lived Intangible Assets Period Increase Decrease IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease		usd
CY2024Q3	RENB	Indefinite Life Intangible Assets And Goodwill Amortization IndefiniteLifeIntangibleAssetsAndGoodwillAmortization		usd
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity File Number EntityFileNumber	001-38758
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	Renovaro Inc.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2559340
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	2080 Century Park East
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 906
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90067
CY2024Q3	dei	City Area Code CityAreaCode	305
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	918-1980
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2024Q3	dei	Trading Symbol TradingSymbol	RENB
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	158717342	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220571	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220467	usd
CY2024Q3	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	1242360	usd
CY2024Q2	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	1108247	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	485228	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	668929	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	1948159	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1997643	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	452212	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	482121	usd
CY2024Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	28750	usd
CY2024Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30043	usd
CY2024Q3	us-gaap	Goodwill Goodwill	118171345	usd
CY2024Q2	us-gaap	Goodwill Goodwill	159330161	usd
CY2024Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19849	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1269633	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	160649686	usd
CY2024Q2	us-gaap	Assets Assets	163129450	usd
CY2024Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	9448683	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5311324	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	102741	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	295361	usd
CY2024Q2	RENB	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	12310000	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	245000	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	245000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	504254	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	493553	usd
CY2024Q3	RENB	Notes Payable Related Parties Net Current NotesPayableRelatedPartiesNetCurrent	2361707	usd
CY2024Q2	RENB	Notes Payable Related Parties Net Current NotesPayableRelatedPartiesNetCurrent	2205996	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	30309917	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	842389	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	710260	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	842389	usd
CY2024Q3	us-gaap	Liabilities Liabilities	23745639	usd
CY2024Q2	us-gaap	Liabilities Liabilities	31152306	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	157617368	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	157617368	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155027245	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155027245	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	15763	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	15504	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	460665481	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	456811911	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368891461	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-324679425	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6297215	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-170846	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	98086998	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	131977144	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	121832637	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	163129450	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5301251	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8290210	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	390189	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	566644	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	47614729	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32385	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27260	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	53338554	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	8884114	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-53338554	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8884114	usd
CY2024Q3	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	9250000	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-120018	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	250080	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	179271	usd
CY2024Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	126598	usd
CY2023Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	8375	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9126518	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-290914	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-44212036	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9175028	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156567973	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156567973	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	64480753	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	64480753	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-44212036	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-9175028	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-6468061	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	34601	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37743975	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9209629	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	46502111	usd
CY2023Q3	RENB	Issuance Of Preferred Stock And Warrants In Private Placement IssuanceOfPreferredStockAndWarrantsInPrivatePlacement	2000000	usd
CY2023Q3	RENB	Issuance Of Preferred Stock And Warrants For Conversion Value IssuanceOfPreferredStockAndWarrantsForConversionValue	2000001	usd
CY2023Q3	RENB	Restricted Shares Issued For Services Rendered Value RestrictedSharesIssuedForServicesRenderedValue	4470000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	983829	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9175028	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-34601	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	46746312	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	131977144	usd
CY2024Q3	RENB	Issuance Of Common Stock Under Private Placement Offering IssuanceOfCommonStockUnderPrivatePlacementOffering	2096181	usd
CY2024Q3	RENB	Restricted Shares Issued For Services Rendered Value RestrictedSharesIssuedForServicesRenderedValue	1400000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	357648	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-44212036	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6468061	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	98086998	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-44212036	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9175028	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32385	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	27260	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-120018	usd
CY2024Q3	RENB	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	9250000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	357648	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	983829	usd
CY2024Q3	RENB	Restricted Shares For Services Rendered RestrictedSharesForServicesRendered	1400000	usd
CY2023Q3	RENB	Restricted Shares For Services Rendered RestrictedSharesForServicesRendered	4470000	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	47614729	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	RENB	Amortization Of Discount On Note Payable AmortizationOfDiscountOnNotePayable	23718	usd
CY2023Q3	RENB	Amortization Of Discount On Note Payable AmortizationOfDiscountOnNotePayable	167765	usd
CY2024Q3	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	195961	usd
CY2023Q3	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-0	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-183701	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-411352	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1953539	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	124303	usd
CY2024Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	46891	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	77055	usd
CY2024Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	31325	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2269	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-16239	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2016328	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2777207	usd
CY2023Q3	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1057875	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1057875	usd
CY2024Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	750000	usd
CY2024Q3	RENB	Repayment Of Finance Agreement RepaymentOfFinanceAgreement	223945	usd
CY2023Q3	RENB	Repayment Of Finance Agreement RepaymentOfFinanceAgreement	187183	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2096181	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2000000	usd
CY2024Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	156947	usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2029183	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2562817	usd
CY2024Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-12751	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-78741	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	104	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1351006	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220467	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1874480	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	220571	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	523474	usd
CY2024Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	5256	usd
CY2024Q3	RENB	Conversion Of Note Payable For Issuance Of Preferred Stock ConversionOfNotePayableForIssuanceOfPreferredStock	0	usd
CY2023Q3	RENB	Conversion Of Note Payable For Issuance Of Preferred Stock ConversionOfNotePayableForIssuanceOfPreferredStock	2000001	usd
CY2024Q3	RENB	Debt Discount Related To Convertible Promissory Notes DebtDiscountRelatedToConvertiblePromissoryNotes	24954	usd
CY2023Q3	RENB	Debt Discount Related To Convertible Promissory Notes DebtDiscountRelatedToConvertiblePromissoryNotes	39474	usd
CY2024Q3	RENB	Cancellation Of Restricted Stock Awards CancellationOfRestrictedStockAwards	83	usd
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zJF3QH0HmMK9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"><b><span id="xdx_86C_z2slANQ4tcI8">Accounting Estimates</span> –</b> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated. Significant estimates include the fair value of assets acquired in a business acquisition, contingent consideration, and equity instruments issued for goods or services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 36pt"> </p>
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-44212036	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-9175028	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	220571	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-368891461	usd
CY2024Q3	RENB	Working Capital Deficit WorkingCapitalDeficit	21087220	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	159464039	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	47614729	usd
CY2024Q2	RENB	Net Definitelife Intangible Assets NetDefinitelifeIntangibleAssets	30043	usd
CY2024Q3	RENB	Net Definitelife Intangible Assets Amortization NetDefinitelifeIntangibleAssetsAmortization	-2501	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Translation And Purchase Accounting Adjustments FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments	1208	usd
CY2024Q3	RENB	Net Definitelife Intangible Assets NetDefinitelifeIntangibleAssets	28750	usd
CY2024Q2	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	159330161	usd
CY2024Q3	RENB	Indefinite Life Intangible Assets And Goodwill Impairment IndefiniteLifeIntangibleAssetsAndGoodwillImpairment	-47614729	usd
CY2024Q3	us-gaap	Indefinite Lived Intangible Assets Translation And Purchase Accounting Adjustments IndefiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments	6455913	usd
CY2024Q3	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	118171345	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7189	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7187	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7187	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7187	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	28750	usd
CY2024Q3	RENB	Interest Expense Related To Note Balance InterestExpenseRelatedToNoteBalance	245000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	357648	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	983829	usd
CY2024Q3	RENB	Employee Service Share Based Compensation Nonvested Award Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardTotalCompensationCostNotYetRecognized	1239528	usd
CY2024Q3	RENB	Employee Service Share Based Compensation Nonvested Award Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardTotalCompensationCostNotYetRecognized	1239528	usd
CY2019Q4	RENB	Upfront Payment UpfrontPayment	10000000	usd
CY2019Q4	RENB	Payment For Expenditures PaymentForExpenditures	760000	usd
CY2021Q3	RENB	Initial Payment InitialPayment	600000	usd
CY2021Q3	RENB	Initial Payment InitialPayment	600000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-53338554	usd
CY2024Q3	us-gaap	Assets Assets	121832637	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5301251	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	390189	usd
CY2024Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	47614729	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32385	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-53338554	usd
CY2024Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	900000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-001811-index-headers.html	Edgar Link	pending
0001731122-24-001811-index.html	Edgar Link	pending
0001731122-24-001811.txt	Edgar Link	pending
0001731122-24-001811-xbrl.zip	Edgar Link	pending
e6117_10-q.htm	Edgar Link	pending
e6117_ex10-2.htm	Edgar Link	pending
e6117_ex31-1.htm	Edgar Link	pending
e6117_ex31-2.htm	Edgar Link	pending
e6117_ex32-1.htm	Edgar Link	pending
e6117_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
e6117_10-q_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
renb-20240930.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
renb-20240930_cal.xml	Edgar Link	unprocessable
renb-20240930_lab.xml	Edgar Link	unprocessable
renb-20240930_def.xml	Edgar Link	unprocessable
renb-20240930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RENB
RENOVARO INC. Stock $renb

2024 Q3 Form 10-Q Financial Statement

#000173112224001811 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RENB RENOVARO INC. Stock $renb

2024 Q3 Form 10-Q Financial Statement

#000173112224001811 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RENB
RENOVARO INC. Stock $renb